IgniteData completed undisclosed amount Series A Round funding
Sector:
Life Science
Data
Software
08/14/2025
Berkshire United Kingdom
IgniteData
completed undisclosed amount Series A Round funding. Investors include
FCA Venture Partners (lead), SpringTide Ventures, Oncology Ventures.
"This round is about scale," said Zach Taft, CEO of IgniteData. "The demand for smarter, faster clinical trials is exploding. We've already validated product-market fit and built deep integrations with top-tier sponsors and sites. This investment enables us to extend our footprint, unlock new data domains, and deliver on the industry's need for intelligent data solutions at a global scale." The company's roadmap includes further expansion of its site network, international deployments, and new product modules designed to unlock previously inaccessible clinical data. IgniteData has already begun leveraging large language models and intelligent data mapping to improve trial speed, data quality, and site-sponsor collaboration.
About
IgniteData is on a mission to revolutionize clinical trials through intelligent automation. By enabling real-time, secure transfer of clinical data between healthcare providers and life science companies, IgniteData accelerates research while reducing burden on clinical sites. With deployments across premier research centers and partnerships with top pharmaceutical sponsors, IgniteData is redefining what's possible in clinical trial operations.
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
